Literature DB >> 17853138

Development of the Texas Spanish Naming Test: a test for Spanish speakers.

Carlos Marquez de la Plata1, B Vicioso, Linda Hynan, H M Evans, Ramon Diaz-Arrastia, Laura Lacritz, C Munro Cullum.   

Abstract

Neuropsychological assessment of Spanish speakers often involves translated versions of English measures, with limited validation data and potential bias due to cultural, educational, and linguistic differences. The Texas Spanish Naming Test (TNT), a 30-item confrontation naming test, was developed for Spanish speakers by systematically selecting culturally salient words. In a sample of 85 minimally educated Spanish speakers, the TNT demonstrated good internal consistency and convergent validity, and showed greater sensitivity than a translated version of the popular Boston Naming Test. Results support the clinical utility of the TNT when dementia among Spanish speakers is suspected.

Entities:  

Mesh:

Year:  2008        PMID: 17853138     DOI: 10.1080/13854040701250470

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  3 in total

1.  Self-ratings of Spoken Language Dominance: A Multi-Lingual Naming Test (MINT) and Preliminary Norms for Young and Aging Spanish-English Bilinguals.

Authors:  Tamar H Gollan; Gali H Weissberger; Elin Runnqvist; Rosa I Montoya; Cynthia M Cera
Journal:  Biling (Camb Engl)       Date:  2012-07

2.  Detecting differential memory performance among Spanish-speaking patients with temporal lobe epilepsy.

Authors:  C Marquez de la Plata; L H Lacritz; R Mitschke; P Van Ness; M Agostini; R Diaz-Arrastia; C M Cullum
Journal:  NeuroRehabilitation       Date:  2009       Impact factor: 2.138

3.  Item analysis of three Spanish naming tests: a cross-cultural investigation.

Authors:  Carlos Marquez de la Plata; Juan Carlos Arango-Lasprilla; Montse Alegret; Alexander Moreno; Luis Tárraga; Mar Lara; Margaret Hewlitt; Linda Hynan; C Munro Cullum
Journal:  NeuroRehabilitation       Date:  2009       Impact factor: 2.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.